Retatrutide Pen

€139,00

Comes with 1 free 3ml vial bacteriostatic water*

Retatrutide is an experimental synthetic peptide that acts as an agonist at three different receptors: GLP-1 (glucagon-like peptide 1), GIP (glucose-dependent insulinotropic peptide), and the glucagon receptor (GCGR). This combination makes it a so-called “triple agonist,” with each of these receptors involved in the regulation of metabolism, energy expenditure, and glucose homeostasis. Retatrutide is being investigated for the treatment of obesity, metabolic syndrome, and type 2 diabetes. In practice, this means that it is a substance that combines multiple effects at once – it suppresses appetite, supports energy expenditure, and improves metabolic balance.

For Research Use Only

Disclosures

Janoshik Certificate of Analysis Retatrutide 10mg • Janoshik Heavy Metals Test Retatrutide 10mg • Janoshik Endotoxin Test 10mg • Janoshik Certificate of Analysis Retatrutide 30mg • Janoshik Certificate of Analysis 30mg Batch nr: RT0392 • Janoshik Heavy Metals Test: Retatrutide 30mg batch RT0392 • Janoshik Endotoxin Test: Retatrutide 30mg batch RT0392 • Efficacy and safety of retatrutide, a novel GLP-1, GIP, and glucagon receptor agonist for obesity tr • Retatrutide-A Game Changer in Obesity Pharmacotherapy • Triple-Hormone-Receptor Agonist Retatrutide for Obesity

Janoshik Certificate of Analysis Retatrutide 10mg